ATE419534T1 - Verwendung von c3a und derivaten als biomarker für kolorektaladenom und/oder -karzinom ; nachweisverfahren und testsystem damit - Google Patents

Verwendung von c3a und derivaten als biomarker für kolorektaladenom und/oder -karzinom ; nachweisverfahren und testsystem damit

Info

Publication number
ATE419534T1
ATE419534T1 AT05772471T AT05772471T ATE419534T1 AT E419534 T1 ATE419534 T1 AT E419534T1 AT 05772471 T AT05772471 T AT 05772471T AT 05772471 T AT05772471 T AT 05772471T AT E419534 T1 ATE419534 T1 AT E419534T1
Authority
AT
Austria
Prior art keywords
colorectal
carcinoma
colorectal adenoma
test system
adenoma
Prior art date
Application number
AT05772471T
Other languages
English (en)
Inventor
Hartmut Juhl
Kerstin David
Anne-Kristin Fentz
Original Assignee
Indivumed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34958684&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE419534(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Indivumed Gmbh filed Critical Indivumed Gmbh
Application granted granted Critical
Publication of ATE419534T1 publication Critical patent/ATE419534T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
AT05772471T 2004-08-13 2005-08-11 Verwendung von c3a und derivaten als biomarker für kolorektaladenom und/oder -karzinom ; nachweisverfahren und testsystem damit ATE419534T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2004/009124 WO2006015616A1 (en) 2004-08-13 2004-08-13 Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system

Publications (1)

Publication Number Publication Date
ATE419534T1 true ATE419534T1 (de) 2009-01-15

Family

ID=34958684

Family Applications (2)

Application Number Title Priority Date Filing Date
AT04764118T ATE376674T1 (de) 2004-08-13 2004-08-13 Verwendung von transthyretin als biomarker zum nachweis von kolorektalen adenomen; verfahren und nachweis-system
AT05772471T ATE419534T1 (de) 2004-08-13 2005-08-11 Verwendung von c3a und derivaten als biomarker für kolorektaladenom und/oder -karzinom ; nachweisverfahren und testsystem damit

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT04764118T ATE376674T1 (de) 2004-08-13 2004-08-13 Verwendung von transthyretin als biomarker zum nachweis von kolorektalen adenomen; verfahren und nachweis-system

Country Status (20)

Country Link
US (2) US7951528B2 (de)
EP (3) EP1843159A1 (de)
JP (2) JP4916441B2 (de)
KR (1) KR20070051328A (de)
CN (2) CN101014859A (de)
AT (2) ATE376674T1 (de)
AU (2) AU2004322162B2 (de)
BR (1) BRPI0419002A (de)
CA (2) CA2577601A1 (de)
DE (2) DE602004009716T2 (de)
DK (2) DK1761779T3 (de)
ES (2) ES2295907T3 (de)
IL (2) IL181131A (de)
MX (2) MX2007001479A (de)
NO (2) NO20070598L (de)
PL (2) PL1761779T3 (de)
PT (2) PT1761779E (de)
SI (1) SI1776587T1 (de)
WO (2) WO2006015616A1 (de)
ZA (1) ZA200701188B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007001479A (es) * 2004-08-13 2007-07-25 Indivumed Gmbh Uso de transtiretina como un biomarcador para adenoma y/o carcinoma colorrectal; metodo para deteccion y sistema de prueba.
EP1775590A1 (de) * 2005-10-11 2007-04-18 Laboratorios S.A.L.V.A.T., S.A. Nicht invasive in vitro Methode zur Detektion von Transitionalzellkarzinomen der Harnblase
JP4748671B2 (ja) * 2006-03-16 2011-08-17 日東紡績株式会社 食道扁平上皮癌マーカーおよびそれを利用した食道扁平上皮癌の判定方法
KR100819122B1 (ko) 2006-09-30 2008-04-04 남명진 췌장암 진단용 키트
WO2009025080A1 (ja) * 2007-08-18 2009-02-26 School Juridical Person Kitasato Institute 大腸癌マーカポリペプチド、及び大腸癌の診断方法
JP5203687B2 (ja) * 2007-12-12 2013-06-05 シスメックス株式会社 動物検査情報提供システム、中央装置、動物検査情報提供方法及びコンピュータプログラム
CN101838683B (zh) * 2008-12-12 2013-09-18 深圳华大基因科技有限公司 一种kras基因和/或braf基因的核苷酸突变位点的检测方法
CN102147396B (zh) * 2010-02-10 2014-01-01 桑建利 人血液样本中脂类分子含量测定及其结直肠腺瘤诊断试剂盒制备与应用
JP2013253780A (ja) * 2010-10-12 2013-12-19 Katakura Industries Co Ltd うつ病の診断のためのデータの提供方法
US10158898B2 (en) 2012-07-26 2018-12-18 Comcast Cable Communications, Llc Customized options for consumption of content
CA2893158A1 (en) * 2012-11-30 2014-06-05 Applied Proteomics, Inc. Method for evaluation of presence of or risk of colon tumors
CN104056277B (zh) * 2013-03-21 2019-07-05 中国人民解放军第二军医大学 Mlh1基因或其表达产物在dkk4高表达的结直肠癌中的应用
JP2017520775A (ja) * 2014-03-28 2017-07-27 アプライド プロテオミクス，インク． 結腸直腸腫瘍を検出するためのタンパク質バイオマーカープロファイル
ES2813829T3 (es) * 2014-08-22 2021-03-25 Abbott Lab Métodos para la detección temprana del cáncer colorrectal
CN105988006A (zh) * 2015-02-10 2016-10-05 张曼 尿液补体c3蛋白的应用
JP2018517892A (ja) 2015-04-10 2018-07-05 アプライド プロテオミクス，インク． 結腸直腸癌と進行腺腫を検知するためのタンパク質バイオマーカーパネル
US20180092874A1 (en) * 2016-10-03 2018-04-05 Lincoln Memorial University Identification and use of very long chain dicarboxylic acids for disease diagnosis, chemoprevention, and treatment
KR102018205B1 (ko) * 2017-07-24 2019-09-05 (주) 바이오인프라생명과학 대장암 진단용 조성물 및 상기 조성물을 이용한 대장암 진단 방법
GB201721569D0 (en) * 2017-12-21 2018-02-07 Belgian Volition Sprl Method for the detection and treatment of colorectal adenomas
GB201808476D0 (en) * 2018-05-23 2018-07-11 Univ Liverpool Biomarkers for colorectal cancer
EP4715839A2 (de) 2019-10-11 2026-03-25 Guardant Health, Inc. Verwendung von zellfreien bakteriellen nukleinsäuren zum nachweis von krebs
EP4179111B1 (de) 2020-07-10 2024-04-03 Guardant Health, Inc. Verfahren zum nachweis von genomischen neuanordnungen unter verwendung zellfreier nukleinsäuren
WO2023282916A1 (en) 2021-07-09 2023-01-12 Guardant Health, Inc. Methods of detecting genomic rearrangements using cell free nucleic acids
US20230280349A1 (en) * 2022-03-01 2023-09-07 The University Of Chicago Methods of Differentiating a Malignant Tumor from a Non-Malignant Tumor
CN116449018B (zh) * 2023-02-14 2023-09-05 浙江大学 一种用于肠腺瘤腺癌诊断的血浆蛋白标记物及应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996298A (en) * 1988-04-20 1991-02-26 New England Deaconess Hospital Corporation Marker for colorectal carcinoma and methods of detecting the same
US5654161A (en) 1995-05-12 1997-08-05 Chiron Diagnostics Corporation Method for diagnosing prostate cancer
US6221621B1 (en) 1997-03-06 2001-04-24 Bard Diagnostic Sciences, Inc. Methods of screening for colorectal cancers in which a complement Factor I or related protein is associated
DE19711111C2 (de) 1997-03-06 1999-09-02 Schering Ag In vitro Nachweis zur Erkennung von Darmtumoren
IL121134A0 (en) 1997-06-22 1997-11-20 Yeda Res & Dev Peptides and antiallergic compositions comprising them
US20020160394A1 (en) 2001-01-24 2002-10-31 Bayer Corporation Regulation of transthyretin to treat obesity
AU2002316299A1 (en) 2001-06-22 2003-01-08 Merck And Co., Inc. Ppar-alpha ligands for the treatment or prevention of cachexia
US7144708B2 (en) * 2001-06-25 2006-12-05 The Cleveland Clinic Foundation Markers of blood barrier disruption and methods of using same
DE10224534A1 (de) 2002-05-31 2003-12-11 Juergen Dolderer Verfahren zum Diagnostizieren des colorektaien Karzinoms in einer Gewebeprobe und Mittel zur Behandlung
JP2005529625A (ja) 2002-06-19 2005-10-06 オンコセラピー・サイエンス株式会社 結腸直腸腫瘍の診断のための方法
NZ562192A (en) 2002-08-06 2009-07-31 Ciphergen Biosystems Inc Use of biomarkers for detecting ovarian cancer
EP1613966A2 (de) * 2003-04-08 2006-01-11 Colotech A/S Verfahren zum nachweis von kolorektalem krebs in menschlichen proben
WO2005008251A2 (en) 2003-07-11 2005-01-27 Praecis Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis
MX2007001479A (es) 2004-08-13 2007-07-25 Indivumed Gmbh Uso de transtiretina como un biomarcador para adenoma y/o carcinoma colorrectal; metodo para deteccion y sistema de prueba.
ES2334671T3 (es) 2004-08-13 2010-03-15 Egomedical Technologies Ag Sistema de ensayo de analitos para determinar la concentracion de un analito en un fluido fisiologico o acuoso.
WO2006102526A2 (en) 2005-03-22 2006-09-28 Government Of The Usa, As Represented By The Secretary, Dept. Of Health And Human Services Identification of biomarkers by serum protein profiling

Also Published As

Publication number Publication date
US20080160515A1 (en) 2008-07-03
KR20070051328A (ko) 2007-05-17
NO20070598L (no) 2007-05-14
PT1776587E (pt) 2009-04-03
PT1761779E (pt) 2008-02-01
DE602004009716T2 (de) 2008-08-28
JP2008509407A (ja) 2008-03-27
EP1776587B1 (de) 2008-12-31
CN101014859A (zh) 2007-08-08
DK1761779T3 (da) 2008-02-25
JP4592753B2 (ja) 2010-12-08
JP4916441B2 (ja) 2012-04-11
PL1761779T3 (pl) 2008-04-30
DE602004009716D1 (de) 2007-12-06
DK1776587T3 (da) 2009-04-20
SI1776587T1 (sl) 2009-06-30
CA2576998A1 (en) 2006-05-26
PL1776587T3 (pl) 2009-06-30
MX2007001254A (es) 2007-10-05
WO2006053592A1 (en) 2006-05-26
US7883842B2 (en) 2011-02-08
NO20070599L (no) 2007-05-14
ZA200701188B (en) 2009-01-28
AU2004322162A2 (en) 2006-02-16
AU2004322162A1 (en) 2006-02-16
IL181132A0 (en) 2007-07-04
ATE376674T1 (de) 2007-11-15
BRPI0419002A (pt) 2007-12-11
CN101014861A (zh) 2007-08-08
ES2322378T3 (es) 2009-06-19
EP1776587B9 (de) 2009-09-16
CA2577601A1 (en) 2006-02-16
WO2006015616A1 (en) 2006-02-16
EP1761779A1 (de) 2007-03-14
AU2004322162B2 (en) 2011-04-28
EP1843159A1 (de) 2007-10-10
JP2008509409A (ja) 2008-03-27
EP1761779B1 (de) 2007-10-24
US20070184499A1 (en) 2007-08-09
AU2005306103A1 (en) 2006-05-26
DE602005012108D1 (de) 2009-02-12
IL181132A (en) 2011-04-28
MX2007001479A (es) 2007-07-25
ES2295907T3 (es) 2008-04-16
US7951528B2 (en) 2011-05-31
IL181131A (en) 2011-03-31
EP1776587A1 (de) 2007-04-25
IL181131A0 (en) 2007-07-04

Similar Documents

Publication Publication Date Title
DE602005012108D1 (de) Verwendung von c3a und derivaten als biomarker für kolorektaladenom und/oder -karzinom ; nachweisverfahren und testsystem damit
MX2021009726A (es) Metodos y sistemas para determinar un estado relacionado con el embarazo de un sujeto.
MX2009008307A (es) Metodos y materiales para identificar el origen de un carcinoma de origen primario desconocido.
DE60332639D1 (de) Verwendung von biomarkern zum nachweis von eierstockkrebs
WO2007035676A3 (en) Methods and materials for identifying the origin of a carcinoma of unknown primary origin
ATE548656T1 (de) Verfahren zur identifizierung von patienten mit erhöhter wahrscheinlichkeit des auftretens eines ovarialkarzinoms und zusammensetzungen dafür
WO2008109075A3 (en) Biomarkers and methods for determining sensitivity to ctla-4 antagonists
ATE556030T1 (de) Ultrasensitiver nachweis von analyten
EP3156925A3 (de) Copd-biomarkersignaturen
EA200500355A1 (ru) Способ обнаружения, характеристики и мониторинга углеводородных месторождений
EA201190026A1 (ru) Ценный документ, способ изготовления контрольного элемента и способ обнаружения загрязнения или истирания документа
ATE408829T1 (de) Verfahren und assaykits zum nachweis mononuklearer zellphänotypen
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
DE60315715D1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
IL189185A0 (en) Use of an endoplasmin fragment and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
WO2009063249A3 (en) Early detection of sepsis
WO2014044791A3 (en) Methods and kits for predicting the sensitivity of a subject to chemotherapy
NO20053276L (no) Fremgangsmate og hjelpemiddel for pavisning av mykoplasma.
WO2011035249A3 (en) Methods for detecting thrombocytosis using biomarkers
WO2007062142A3 (en) Method for identifying biomarkers associated with cancer
DK1416278T3 (da) Fremgangsmåder til forbedret diagnosticering af dysplasier
FI20011908A0 (fi) Menetelmä vatsasyövän osoittamiseksi
DE69736122D1 (de) Verwendung eines prostatatumor auslösenden gens zum aufspüren von krebszellen
WO2022204378A3 (en) Identification of rna biomarkers in colorectal cancer
BRPI0514314A (pt) método para detecção de e discriminação entre adenoma colorretal e/ou carcinoma colorretal, método para monitoramento de desenvolvimento e/ou curso e/ou de tratamento de adenoma colorretal e/ou carcinoma colorretal, uso de c3a ou derivado do mesmo, sistema de teste, conjunto compreendendo moléculas, método para determinar se um composto é efetivo no tratamento do adenoma colorretal e/ou carcinoma colorretal

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1776587

Country of ref document: EP